RecruitingNot Applicable

Interstitial Lung Disease Research Unit Biobank

United States1,000 participantsStarted 2021-08-09

Plain-language summary

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
. The participant is ≥ 18 years of age.
. The participant has signed an approved consent for this study (living patients only)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.

Timeframe: Enrollment to Year 10

Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.

Timeframe: Enrollment to Year 10

Correlate biological samples with individual longitudinal clinical data.

Timeframe: Enrollment to Year 10

Provide biological samples to researchers performing studies in ILD and RLD.

Timeframe: Enrollment to Year 10

Collect historical data and imaging from deceased patients with ILD.

Timeframe: Enrollment to Year 10

Trial details

NCT IDNCT05392881

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2031-08-01

Contact for this trial

Kimberly Donnelly, Ph.D.

913-588-6067 kdonnelly@kumc.edu

View on ClinicalTrials.gov More Interstitial Lung Disease trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
. The participant is ≥ 18 years of age.
. The participant has signed an approved consent for this study (living patients only)

What they're measuring

Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.

Timeframe: Enrollment to Year 10

Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.

Timeframe: Enrollment to Year 10

Correlate biological samples with individual longitudinal clinical data.

Timeframe: Enrollment to Year 10

Provide biological samples to researchers performing studies in ILD and RLD.

Timeframe: Enrollment to Year 10

Collect historical data and imaging from deceased patients with ILD.

Timeframe: Enrollment to Year 10